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Abstract 
The zebrafish (Danio rerio) is increasingly being used to study basic vertebrate biology and human 
disease using a rich array of in vivo genetic and molecular tools. However, the inability to readily modify 
the genome in a targeted fashion has been a bottleneck in the field. Here we show that improvements in 
artificial transcription activator-like effector nucleases (TALENs) provide a powerful new approach for 
targeted zebrafish genome editing and functional genomic applications1–5. Using the GoldyTALEN 
modified scaffold and zebrafish delivery system, we show this enhanced TALEN toolkit demonstrates a 
high efficiency in inducing locus-specific DNA breaks in somatic and germline tissues. At some loci, this 
efficacy approaches 100%, including biallelic conversion in somatic tissues that mimics phenotypes seen 
using morpholino (MO)-based targeted gene knockdowns6. With this updated TALEN system, we 
successfully used single-stranded DNA (ssDNA) oligonucleotides (oligos) to precisely modify sequences 
at predefined locations in the zebrafish genome through homology-directed repair (HDR), including the 
introduction of a custom-designed EcoRV site and a modified loxP (mloxP) sequence into somatic tissue 
in vivo. We further show successful germline transmission of both EcoRV and mloxP engineered 
chromosomes. This combined approach offers the potential to model genetic variation as well as to 
generate targeted conditional alleles. 
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Abstract
The zebrafish (Danio rerio) is increasingly being used to study basic vertebrate biology and 
human disease using a rich array of in vivo genetic and molecular tools. However, the inability to 
readily modify the genome in a targeted fashion has been a bottleneck in the field. Here we show 
that improvements in artificial transcription activator-like effector nucleases (TALENs) provide a 
powerful new approach for targeted zebrafish genome editing and functional genomic 
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applications1–5. Using the GoldyTALEN modified scaffold and zebrafish delivery system, we 
show this enhanced TALEN toolkit demonstrates a high efficiency in inducing locus-specific 
DNA breaks in somatic and germline tissues. At some loci, this efficacy approaches 100%, 
including biallelic conversion in somatic tissues that mimics phenotypes seen using morpholino 
(MO)-based targeted gene knockdowns6. With this updated TALEN system, we successfully used 
single-stranded DNA (ssDNA) oligonucleotides (oligos) to precisely modify sequences at 
predefined locations in the zebrafish genome through homology-directed repair (HDR), including 
the introduction of a custom-designed EcoRV site and a modified loxP (mloxP) sequence into 
somatic tissue in vivo. We further show successful germline transmission of both EcoRV and 
mloxP engineered chromosomes. This combined approach offers the potential to model genetic 
variation as well as to generate targeted conditional alleles.
Keywords
zebrafish; TALEN; genome engineering; loxP
Custom zinc finger nucleases (ZFNs) 7–9 and TALENs1–5 have been used introduce locus-
specific double-stranded breaks in the zebrafish genome, generating dozens of mutant 
alleles10. Recent work has been facilitated by the relatively straightforward DNA base 
recognition cipher underlying TALEN technology11,12. However, the efficacy of previously 
described custom sequence-specific nucleases was limiting in some applications1–5,7–9. For 
example, standard TALENs using the pTAL scaffold13 (Supplementary Fig. 1) targeting 
exon 2 of the zebrafish ponzr1 locus14 resulted in a measurable level of locus modification 
in somatic tissue (median value of 5%; Fig. 1b–c). This pTAL-ponzr1 pair yielded 4 
germline-transmitting founder animals carrying a mutation in ponzr1 out of the 24 tested 
(Supplementary Fig. 3d). TALENs against a second locus (crhr1) using the pTAL scaffold 
yielded a modest rate of locus modification (<1%; Fig. 1b–c). These results are 
characteristic of the standard TALEN efficacy range demonstrating room for improvement.
Multiple TALEN scaffold designs have been described13,15,16, including those with 
different N- and C-terminal truncations, diverse FokI nuclease linkers, and various nuclear 
localization sequences. To improve in vivo efficacy, we tested the GoldyTALEN scaffold 
(Supplementary Fig. 1; Supplementary Fig. 2) in an mRNA expression vector backbone 
(pT3TS17) using DNA analysis that measures the loss of a restriction enzyme recognition 
sequence at the TALEN cut site (Fig. 1a). Using the same recognition domains in the 
GoldyTALEN scaffold, there is a 6-fold increase in somatic gene modification at the ponzr1 
locus (Fig. 1b–c; Supplementary Fig. 3b) over the pTAL scaffold. The germline 
modification rate was similarly increased when switching scaffolds, from 17% (4/24; pTAL-
ponzr1; Supplementary Fig. 3d) to 71% (10/14; GoldyTALEN-ponzr1; Supplementary Fig. 
3e). We also detected improved efficacy using a cell-free assay system with in vitro 
translated TALEN protein and purified ponzr1 PCR DNA (Fig. 1d). The GoldyTALENs 
against crhr1 showed an increase in the genome modification rate, improving from <1% to 
7% median cutting efficacy (Fig. 1b–c; Supplementary Fig. 3c). Sequence comparisons of 
pTAL and GoldyTALEN scaffolds in both loci demonstrate similar indels at the cut site, 
which is diagnostic of NHEJ repair (Supplementary Fig. 3).
Bedell et al. Page 2













To further test the efficacy of the GoldyTALEN scaffold, we generated TALENs against 
three additional loci (moesina, ppp1cabb and cdh5; Supplementary Fig. 4a). We observed 
efficient gene modification at each locus (5 out of 5 loci total; Fig. 1 and Fig. 2a). In three 
instances, the mutagenesis efficiency ranged from 70 to 100% as demonstrated by loss of the 
restriction enzyme recognition sequence at the TALEN cut sites (Fig. 2a) and DNA 
sequence analyses (Supplementary Fig. 4b–d) of amplicons from pooled injected embryos. 
To determine the time-course of the GoldyTALEN-induced changes, we examined 
restriction enzyme nuclease activity at 256-cell, 28 hours post fertilization (hpf) and 50 hpf 
stages. A majority of the DNA was modified by the 256-cell stage (Supplementary Fig. 5). 
Together, these results indicate early, efficient gene targeting in somatic tissues including 
biallelic conversion in some animals. Somatic targeting efficacy using the GoldyTALEN 
scaffold compares favorably with previous TALEN scaffolds in zebrafish, with 3 of 5 
GoldyTALENs demonstrating as high or higher mutation frequency as any of the previously 
reported loci using the first generation TALEN systems1–5.
In response to the increased efficacy of the GoldyTALENs, we asked whether injection of 
TALENs could recapitulate a known MO6 loss of function phenotype. We conducted a 
dose-response curve of the moesina, ppp1cab and cdh5 GoldyTALEN pairs, optimizing 
GoldyTALEN concentration to the number of embryos with biallelic changes, and percent 
dead or malformed embryos (Supplementary Fig. 6). Embryos injected with either cdh5 
GoldyTALENs (Fig. 2d) or MOs18 (Fig. 2c) displayed similar vascular phenotypes: 
pronounced cardiac edema (Fig. 2b, top panels), loss of patent lumens in the Tg(fli1-egfp)y1 
vasculature19 (Fig. 2c, d, bottom panels), and loss of circulating Tg(gata1:dsred)sd2 red 
blood cells20 (Fig. 2c, d, bottom panels; Supplementary Movies 1–3). A similar pericardial 
edema phenotype was observed in F1 offspring from F0 cdh5 founder incrosses (data not 
shown), suggesting specificity of the phenotype described in F0s to cdh5 loss of function. 
Furthermore, cdh5 GoldyTALEN-injected embryos display little or no Cdh5 protein 
(Supplementary Fig. 7). Together, these results indicate that the GoldyTALEN platform can 
achieve efficient biallelic targeting recapitulating known loss-of-function phenotypes. 
Furthermore, these data demonstrate that GoldyTALENs have the potential to be a 
complementary, but distinct, approach to MO-based somatic phenotype assessment.
The biallelic GoldyTALEN-injected fish were raised to assess germline mutation 
transmission. The moesina, ppp1cab or cdh5 F0 founders were outcrossed. Ten pooled F1 
embryos were screened and displayed a 9 to 55% locus mutation frequency (Supplementary 
Fig. 8a–c). From two founder F0 outcrosses per locus, 10 individual F1 embryos were 
sequenced with mutant alleles identified in 20% to 100% of the F1 offspring 
(Supplementary Fig. 8). Furthermore, in two out of three of these loci we detected germline 
mosaicism, suggesting several independent repair events. These data indicate that the 
efficient somatic TALEN targeting is effectively passed through the germline.
Recent in vitro work demonstrates that ssDNA can be an effective donor for HDR-based 
genome editing at a ZFN-induced double-stranded break21,22. With the highly efficient 
genome modification success of GoldyTALENs, we hypothesized that synthetic oligos 
designed to span the predicted TALEN cut site could serve as a template for HDR in vivo 
(Fig. 3). Using ponzr1 as a test locus, we introduced an EcoRV restriction site by co-
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injection of ponzr1 GoldyTALENs and a ssDNA oligo (Fig. 3a). In these experiments, 42 of 
74 injected embryos displayed a detectable level of chromosomes containing the introduced 
EcoRV sequence with an estimated 9% ratio of converted chromosomes in these animals 
(Supplementary Fig 9a). Sequence analysis indicated two precisely modified chromosome 
events from different larvae (Supplementary Fig. 9b) demonstrating successful somatic 
HDR at the ponzr1 locus. Other events show precise addition at the 3′ end while small indels 
were noted at the 5′ side of the modification site (Supplementary Fig. 9c). Several homology 
arm lengths were tested for the highest HDR signal. In this experimental approach, an 
increase in homology arm length that spanned the TALEN binding site decreased the 
frequency of HDR events (Supplementary Table 1).
To test whether the HDR sequence modification was stably maintained in zebrafish somatic 
tissue, fin biopsies from two month-old fish were assayed for addition of the EcoRV 
sequence at the ponzr1 locus. Out of 186 fish, 8 showed a visible incorporation of EcoRV 
(Supplementary Fig. 9c). To determine whether a lack of somatic EcoRV incorporation also 
indicated a lack of germline incorporation, 13 randomly selected fish with EcoRV-negative 
fin biopsies were outcrossed. The offspring from all 13 adults were negative for EcoRV 
incorporation at the ponzr1 locus (clutch sizes ranged from 16–96 embryos). Therefore, fin 
biopsy positive fish were prioritized for determining germline transmission. Outcross 
embryos from three out of four fin tissue positive fish yielded clutches with introduction of 
the EcoRV site at the ponzr1 locus (Fig. 3b). Two out of three of these germline fish 
demonstrated precise EcoRV addition (Fig. 3c).
We next asked whether TALEN/oligo co-injection could introduce larger sequences such as 
a loxP site, an essential step in making Cre-dependent conditional genetic alleles. We used 
TALENs against an intron in the crhr2 gene and a ssDNA oligo were used to add a modified 
loxPJTZ17 (mloxP)23 site at this location (Fig. 4a). PCR analysis demonstrates somatic 
introduction of the mloxP sequence at the crhr2 TALEN cut site (Supplementary Fig. 10a). 
Sequence characterization confirmed integration of the mloxP site in 3 assayed somatic 
chromosomes (Supplementary Fig. 10b). A similar method was used to introduce an mloxP 
sequence at the ponzr1 locus (Supplementary Fig. 11a). Sequencing confirmed precise 
somatic addition at this locus (Supplementary Fig. 11b–c).
Maintenance of somatic mloxP-modified crhr2 chromosomes by fin bioposy was used to 
identify germline transmission of the mloxP sequence. Positive chromosomes were detected 
by quantitative PCR in 20 of 53 animals (Supplementary Fig. 10a). Embryos were obtained 
from 16 of the somatic-positive fish as well as 42 fish that had not been pre-screened by 
PCR. Both groups transmitted HDR events through the germline (Fig. 4b). However, no 
significant enrichment for likely germline transmitting animals was noted, perhaps due to 
the less stringent PCR assay than used for ponzr1. In total, 6 out of 58 injected animals 
transmitted mloxP-modified chromosomes through the germline at the crhr2 locus (Fig. 4b). 
Sequence confirmation of three of these fish demonstrated a precise HDR event as well as 
other, non-precise events (Fig. 4c).
Here, we focused on local genome editing changes induced by TALENs, especially those 
induced by HDR. However, more complete analyses will be required to assess any, off-
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target effects of TALENs or ssDNA-based HDR. Whole genome sequencing on germline-
transmitting fish from different parental lines would be particularly instructive. Should this 
analysis demonstrate off-target mutations, TALENs using obligate heterodimer-based 
nuclease fusions have recently been reported as an alternative approach3,5,24. Using obligate 
heterdimers in the GoldyTALEN scaffold is one future method for potentially optimizing 
HDR-directed gene editing specificity.
To our knowledge, these results represent the first description of successful HDR in 
zebrafish and the first demonstration of HDR using ssDNA as a donor template in vivo. This 
approach complements the error-prone NHEJ toolkit for model organisms (Fig. 5). The use 
of ssDNA facilitates an array of genome changes, including the introduction of single 
nucleotide polymorphisms for vertebrate genetic applications. The asymmetry in precise 
editing suggests an additional mechanism for genome editing that incorporates both HDR 
and NHEJ (Fig. 5). For example, the donor ssDNA may serve as a primer for new strand 
synthesis at the TALEN break. Extension from the 3′ end of the oligo would create long 
regions of homology for recombination. However, the 5′ end of the oligo limits the extent of 
strand invasion and a limited opportunity for HDR. This leads to 5′ end resolution by either 
HDR or NHEJ. For applications where new sequences are introduced into non-coding 
genomic regions, such as the introduction of loxP sites into intronic sequences, either event 
will likely be of high utility.
Using the zebrafish, we report an updated TALEN system for use in genome modification 
and functional genomic applications. The high efficacy enables new approaches, including 
somatic gene targeting for reverse genetics applications. Furthermore, we show that 
synthetic ssDNA oligos can be used with this TALEN system for genome editing including 
the precise introduction of exogenous DNA sequence at a specific locus. Although deployed 
here in zebrafish, this approach has the potential to be effective for in vivo applications in a 
wide array of model organisms.
Methods Summary
TALENs were assembled via the GoldenGate method13. For ease of analysis, TALENs 
recognition sequences flanked a unique restriction site within the targeted gene. TALEN 
RVDs were cloned into a pT3TS17-driven TALEN scaffold, and mRNA was injected into 
single-cell zebrafish embryos. The injected larvae were either molecularly tested or raised 
for germline mutation analysis. Somatic and germline TALEN-induced mutations were 
evaluated via PCR and restriction fragment length polymorphisms. To induce HDR events, 
singe-stranded DNA oligonucleotides with either an EcoRV or mloxP site were designed 
with short homology arms around a TALEN target site and were injected into one-cell 
zebrafish embryos. PCR analysis of modified loci was used to detect the resulting somatic 
and germline HDR events. Detailed methods can be found in the Supplementary 
Information.
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The software developed by the Bogdanove laboratory (https://boglab.plp.iastate.edu/
node/add/talen) was initially used to find candidate binding sites as described13. Three 
criteria were used for TALEN design. First, TALEN binding sites were selected that ranged 
from 15–25 bases in length. Second, the spacer length was initially selected to be 14 to 18 
base pairs (bps), but subsequent GoldyTALEN designs were restricted to 15–16 bps. 
Additionally, when possible TALEN cut sequences were selected around a restriction 
enzyme centrally located within the spacer. To simplify the TALEN design process, a free, 
open access software (Mojo Hand) was created and made available online 
(www.talendesign.org). Mojo Hand downloads sequence from NCBI and uses an exhaustive 
database of commercially available restriction enzymes to identify TALEN binding sites 
with a restriction enzyme site in the spacer region to simplify downstream analysis (Neff et 
al (unpublished)). Mojo Hand also features a BLAST interface that will search genomes for 
potential second site effects.
TALEN Binding Sites and Spacer Regions
The ponzr1 TALEN recognition sequences are: left TALEN 5′-
GTGAGCACCCAGCGGACCTCCTCT-3′ and right TALEN 5′-
ATCAGAACAACAGTCAGAGAT-3′. Between the two binding sites is an 18 bp spacer 
with a BstNI sequence (GGAACCTGGACCACGGGC, BstNI underlined). The crhr1 
TALEN recognition sequences are: left TALEN 5′-
TGCAACACTGAGCTCTGTAAACCT-3′ and right TALEN 5′-
CTGCTGCCGACTGGACCCTGAGGT-3′. Between the two binding sites is a 15 bp spacer 
with a BstUI site (GTCCGCGTGTGGCGA, BstUI underlined). The moesina TALEN 
recognition sequences are: left TALEN 5′-ACCCAGAAGACGTTT-3′ and right TALEN 5′-
CTTTGAGTGGCCTCCT-3′. Between the two binding sites is a 15 bp spacer with an XmnI 
site (CTGAGGAACTGATTC, XmnI underlined). The ppp1cab TALEN recognition 
sequences are: left TALEN 5′-CCACCAGAGAGTAACT-3′ and right TALEN 5′-
GCCTCTGTCAACATAGT-3′. Between the two binding sites is a 15 bp spacer with a BsII 
site (ACCTATTTCTGGGAG, BsII underlined). The cdh5 TALEN recognition sequences 
are: left TALEN 5′-CTCCTCAACATACATACT-3′ and right TALEN 5′-
ACAAATGATTCATCTT-3′. Between the two binding sites is a 16 bp spacer with a HincII 
site (GGAGAGTTAGTTGACA, HincII underlined). The crhr2 binding sites are: left 
TALEN 5′-GTCAAATCTGCAGCTCCACGCTT-3′ and right TALEN 5′-
CCTCTGCCTCTGACTCTGT-3′. Between the two binding sites is a 15 bp spacer 
(CACGCCTCAGCAAAC).
TALEN Constructs
TALEN assembly of the RVD-containing repeats was conducted using the Golden Gate 
approach13. Once assembled, the RVDs were cloned into a pT3TS destination vector with 
the appropriate TALEN backbone to generate mRNA expression plasmids – pT3TS-TAL 
(pTAL) and pT3TS-GoldyTALEN (GoldyTALEN). In vitro transcription of TALEN mRNA 
was conducted by linearizing the expression plasmids with SacI endonuclease at 37°C for 2–
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3 hours, transcribing the linearized DNA (T3 mMessage Machine kit, Ambion) and 
purifying the mRNA by phenol/chloroform extraction (T3 mMessage Machine kit user 
manual protocol) for injection.
TALEN Mutation Screening
One-cell embryos were microinjected with 50–400 pg of TALEN mRNA. The dose of each 
pair of TALENs injected was empirically determined, with up to a 3-fold difference noted 
between different TALEN pairs. In each case, conditions were used where over 50% 
embryos survived post-injection. Genomic DNA for Figures 1, 3 and 4 were collected at 2–4 
dpf from 24–32 individual larvae by incubating in 50mM NaOH at 95°C, followed by 
cooling to 4°C and adding 1/10 volume 1M Tris-HCL pH 8.025. Genomic DNA for Figure 2 
was isolated from groups of 10 larval zebrafish using DNAeasy Blood and Tissue kit 
(Qiagen). Genotyping was conducted using PCR followed by restriction enzyme digest. For 
ponzr1, the primers were 5′-GTTCACACAAAATGTCTCTCAAGTCTCTAAATC -3′ and 
5′-AGTGGCCAGTGAGTGTATGTTACCT -3′. For crhr1 the primers were 5′-
CGTGAAAGAGACAGCGAAGGGATTG -3′ and 5′-
AGAAACTACCATTGTCACACTGAGCGAAG -3′. The primers for moesina were 5′-
GTTACGGCTCAAGACGTC-3′ and 5′-CAGGATGCCCTCTTTAAC-3′. The primers for 
ppp1cab were 5′-GATGTTCATGGTCAGTAC-3′ and 5′-
TGATTGAGGCACATTCATGG-3′. The primers for cdh5 were 5′-
TTGTTGTCCTTGCAAAGCTG-3′ and 5′-TCTAGAGGATTCGCTGAT-3′. The primers 
for crhr2 were 5′-CCCTGATTGTGGAACTTTTCAGAACGTA-3′ and 5′-
TGGTTTGGAATTAGTGCAGCATGAGTA-3′. Mutations were assessed by loss of 
restriction enzyme digestion. To sequence-verify mutations, the gel-purified, uncut PCR 
products were cloned into the TOPO® TA Cloning® Kit (Invitrogen).
Analysis of cdh5
A cdh5 morpholino18 was injected at the 1–4 cell stage into Tg(fli1:efgp)y1 embryos19. The 
vascular phenotype of the MO and the GoldyTALEN-injected embryos were assessed using 
a confocal microscope. Antibody staining using the cdh5 antibody26 was performed as 
described18.
Genome Editing
For the ponzr1 locus, a ssDNA oligo was designed to target the spacer sequence between the 
TALEN cut sites. The oligo extends to half the length of the TALEN recognition site. An 
EcoRV site (5′-GATATC-3′) or a modified loxP (mloxP) site (5′-
ATAACTTCGTATAGCATACATTATAGCAATTTAT-3′) was introduced near the center 
of the oligo resulting in a 20-base homology arm on the 5′ end and an 18-base homology 
arm on the 3′ end. For the crhr2 locus, the crhr2 mloxP oligo (5′ –
TCAAATCTGCAGCTCCACGCTTCACGCATAACTTCGTATAGCATACATTATAGCA
AT TTATGCATATCTCCTTTTCTCGAAAAGTAAG – 3′) was designed to replace the 3′ 
TALEN binding site with an mloxP site while providing 27 bases of homology at both 5′ 
and 3′ end. The oligos were ordered from Integrated DNA Technologies (IDT) and purified 
using the Nucleotide Removal Kit (Qiagen).
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One-cell embryos were microinjected with both the GoldyTALEN mRNA and ssDNA 
donor. The ssDNA oligo dose was varied to improve the rate of HDR without impacting 
toxicity beyond 50% embryonic death post injection. For the ponzr1 locus, 50–75 pg of 
ponzr1 GoldyTALEN mRNA and 50–75 pg of the ssDNA donor. For the crhr2 locus, 50 pg 
of crhr2 GoldyTALEN mRNA was injected with either 25 pg or 50 pg of crhr2 mloxP 
oligo. Genomic DNA was isolated as described above. If the embryos were injected with the 
EcoRV oligo, PCR was conducted using the same primers as listed above and the product 
was digested using EcoRV. The full-length amplicon from EcoRV-positive larvae was 
cloned into a TOPO® TA Cloning® Kit (Invitrogen). Colony PCR was used to identify 
plasmids with EcoRV-modified inserts. Those plasmids were subsequently sequenced to 
confirm EcoRV integration and determine details of sequence changes due to HDR. If the 
embryos were injected with the mloxP oligo, the genomic DNA was amplified using the 
same forward primer as listed above and a mloxP reverse primer, 5′-
ATAAATTGCTATAATGTATGCTATACGAAGT-3′, or the same reverse primer as listed 
above and a mloxP forward primer, 5′-
ACTTCGTATAGCATACATTATAGCAATTTAT-3′. For sequence analysis, the complete 
amplicon was produced using the gene-specific primers listed above and cloned (TOPO® 
TA Cloning® Kit, Invitrogen). Colony PCR was used to find mloxP-positive plasmids. The 
positive plasmids were sequenced for confirmation of mloxP integration.
Injected fish from the same batch of somatically screened embryos were raised. When the 
fish were at least two months old, fin tissue was obtained using standard protocols pre-
approved by Institutional Animal Care and Use Committee guidelines. The fish were 
anesthetized using Tricaine (approximately 200 μg/ml). The tail fins were trimmed with a 
fresh razor blade for each fish to prevent contamination. The most caudal 2–3mm of fin was 
biopsied and placed on ice until all fin biopsies were collected. 150 μl of 50mM NaOH was 
added to the fin clips prior to DNA isolation (above). Those fish that maintained somatic 
modifications were outcrossed to wild type fish and the embryos were screened for germline 
mutations. Somatic mutations were determined by RFLP analysis for EcoRV integration 
into ponzr1. Quantitative PCR of mloxP integrations into the crhr2 locus were compared to 
a reference gene, RPS6Kb1. Twenty of 53 fish included >0.2% of their DNA containing 
mloxP integrations into crhr2 (CT of ≤10) and were prioritized for screening. For mloxP 
integration into crhr2, 42 fish that were not screened by quantitative PCR were also tested 
for germline transmission and no appreciable difference in germline transmission between 
these two methods was noted.
The PCR product for germline HDR events were cloned and sequenced. In one clone that 
contained a sequence insertion along with integration of the EcoRV site, the sequencing was 
more difficult presumably because the insertion tended to form a hairpin and disrupted the 
sequencing reaction. To obtain the full sequence, the PCR product was digested with EcoRV 
and each half sequenced separately. Similar cloning difficulties were observed in some 
crhr2 lineages, but not for precise HDR or limited sequence addition.
The sequence addition process using ssDNA oligos is inherently less efficient than the 
relatively simpler NHEJ events seen in the GoldyTALEN-alone injected embryos. 
Therefore, to identify a precise HDR event, more fish will need to be raised and screened. 
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Fin clipping the fish for maintenance of the somatic insertion may be a good indicator of 
germline transmission. Continued investigation into the mechanism of HDR incorporation in 
zebrafish will likely increase the efficiency of this technique.
Zebrafish Work
The zebrafish work was conducted under full animal care and use guidelines with prior 
approval by the local institutional animal care committee’s approval. Danio rerio transgenic 
lines were described previously: Tg(fli1:efgp)y1 vasculature19 and Tg(gata1:dsred)sd2 red 
blood cells20.
Data Analysis and Statistics
ImageJ was used to quantify the percent GoldyTALEN-modified chromosomes by 
measuring the intensity of bands post-digestion. For each gel, the background was 
subtracted and each lane isolated to generate individual intensity plot profiles. A straight line 
was drawn across the bottom of each plot to eliminate inconsistencies caused by baseline 
skew. The intensity measurement for each band was added together to determine total 
intensity. To calculate percent cutting, the intensity of the top band was divided by the total 
intensity. A student’s T-test was used to compare TALEN scaffold cutting efficiencies. To 
measure the differences between pTAL and GoldyTALEN at two different loci, several 
whisker plots were constructed (Figure 1C). The interquartile range (IQR; Q3-Q1) is shown 
as a box, with the median value (Q2) being the horizontal line within the box. The upper and 
lower whiskers are the highest and lowest data point within 1.5 times the IQR added or 
subtracted from Q3 or Q1, respectively.
A similar approach was used to calculate the percent of HDR-converted chromosomes. The 
intensity of the digested products were added together and divided by the total intensity. The 
percent of embryos with an HDR signal was determined by dividing the number of embryos 
with signal by the total number of screened embryos.
Cell-free TALEN Restriction Endonuclease Assay
In vitro translation of 2 μg of each TALEN mRNA was conducted using the TNT® Quick 
Coupled Transcription and Translation System (Promega). 5 μg of the ponzr1 PCR product 
was included in the assay mix during in vitro translation of different TALEN combinations, 
allowing the translation and in vitro nuclease digestion to occur simultaneously. The highest 
signal was obtained when translation and digestion steps were conducted simultaneously 
presumably because the TALEN protein is unstable using these in vitro conditions. 
Translation was conducted for 2 hours at 30°C. To further facilitate TALEN in vitro 
nuclease activity, the assay mix was diluted five fold in in vitro digestion buffer (20mM 
Tris-HCl pH 7.5, 5mM MgCl2, 50 mM KCl, 5% Glycerol, and 0.5mg/ml BSA)27. The assay 
mix was incubated at 30°C for 4 hours. The digested DNA was purified using the PCR 
Purification kit (Qiagen), concentrated via ethanol precipitation, and run on a 2% agarose 
gel. No TALEN mRNA was added to the negative control.
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Figure 1. Second-generation GoldyTALEN scaffold improves genome-editing efficacy
a, A schematic showing the layout of TALEN target sites. TALENs were targeted to 
flanking sequences surrounding a restriction enzyme site for easy screening through 
introduction of a restriction fragment length polymorphism. b, Relative activity of the 
GoldyTALEN and pTAL scaffolds at two loci, ponzr1 and crhr1. Under each lane is the 
percent uncut DNA of a single larva, illustrating the increased activity of GoldyTALEN. c, 
Whisker plots of the percent uncut DNA demonstrates TALEN cutting efficiency at two 
loci. ponzr1 TALENs demonstrate a significant (p < 10−16), 6-fold increase in activity using 
GoldyTALEN. crhr1 TALENs also demonstrate a significant (p < 10−9), 15-fold increase in 
activity. n = number of embryos screened, mdn = the median percent cut. d, The ponzr1 
GoldyTALENs were more active in a cell-free restriction enzyme digestion assay. ponzr1 
DNA is labeled in both uncut and cut forms. − ctrl = negative control.
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Figure 2. Increased TALEN efficiency results in biallelic gene targeting
a, GoldyTALENs were designed against the moesina, ppp1cab and cdh5 genes. All three 
gene targets contained a restriction enzyme site within the spacer region between the 
TALEN binding sites. Injection of GoldyTALEN mRNAs demonstrated a nearly complete 
loss of the restriction enzyme site in the amplicons of somatic tissue. Each lane is the 
amplification product from a group of 10 embryos. Mutant seq (%) = percentage of 
amplicons that carry mutant sequences as determined by sequencing 10 clones 
(Supplementary Fig. 4). b–d, Injection of cdh5 GoldyTALENs (d) phenocopies the MO-
based loss-of-function phenotype (c). Brightfield images (top panels) show pronounced 
cardiac edema (arrows) in both GoldyTALEN (d)- and MO (c)-injected larvae at 2 days post 
fertilization. Using the Tg(fli1-egfp)y1 line, the intersomitic vessels were visualized (bottom 
panels) and show a loss of lumen formation (white arrow) in both the MO (c)- and 
GoldyTALEN (d)-injected larvae. The Tg(gata1:dsred)sd2 line revealed reduced circulation 
in GoldyTALEN- and MO-injected larvae, demonstrated by the increase in red fluorescence 
in the confocal images (see Movies 1–3).
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Figure 3. Targeted genome editing using GoldyTALENs
a, A schematic of the ponzr1 locus with the ssDNA sequence used to introduce a targeted 
exogenous EcoRV sequence into the genome in vivo. The left and right TALEN binding sites 
are shown in red and orange, respectively, and the spacer region is in blue. b, A 
representative gel demonstrating germline transmission of the HDR-based EcoRV sequence 
in 3 out of 4 fin tissue-positive fish. c, Sequence analysis of the three germline-transmitting 
lines. The first fish transmitting HDR-based genome changes through the germline (#1) 
yielded 7 out of 96 embryos with an incorporated EcoRV site. The genomes of all 7 embryos 
showed the same modified sequence. The second founder fish (#2) yielded 7 out of 46 
embryos with EcoRV incorporation. All 7 embryos showed precise HDR-based addition of 
the EcoRV sequence. The third fish with germline transmission (#3) yielded 5 out of 18 
embryos with an incorporated EcoRV site, and showed a mosaic germline as demonstrated 
by offspring with three different modified sequences. One embryo included precise HDR-
based EcoRV addition. The other 4 embryos contained sequence insertions on the 5′ end 
with two embryos each harboring the specific sequences changes.
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Figure 4. Germline mloxP integration into the crhr2 locus
a, A diagram of the TALEN target sites with the mloxP ssDNA oligo. The left and right 
TALEN target sequences are red and orange, respectively, the spacer region is blue, and the 
oligo’s right homology arm is in purple. The mloxP sequence is underlined. b, Germline 
screening of the crhr2 locus. 53 adult fish were prescreened via fin biopsy. Of those 
prescreened, 20 demonstrated mloxP maintenance. 16 F0s were outcrossed with 2 showing 
germline transmission. 42 unscreened F0s were outcrossed and 4 demonstrated germline 
transmission. c, Sequence confirmation of three mloxP germline fish. One fish demonstrated 
precise germline HDR while two showed indels. In #NS24, we saw the reverse complement 
of the mloxP was noted (shaded in grey).
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Figure 5. in vivo TALEN-induced genome editing outcomes
TALENs efficiently create double-stranded breaks in chromosomal DNA and catalyze three 
major outcome classes. First, error-prone NHEJ produces an indel in and near the spacer 
region of the TALEN binding site. If a complementary ssDNA oligonucleotide is also 
added, two different outcomes are noted. First, HDR precisely uses the exogenous sequence 
information in the ssDNA to add sequence at the cut site. Alternatively, ssDNA acts as a 
primer for 3′ integration of the oligonucleotide but the 5′ end undergoes error-prone 
NHEJ22.
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